Neoantigen Targeted Therapies Market : Technology Advancements, Industry Insights, Trends And Forecast 2033

Posted by Amruta Pritam on February 23rd, 2024

The Neoantigen Targeted Therapies Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Neoantigen Targeted Therapies Market:

https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report

According to The Business Research Company’s Neoantigen Targeted Therapies Global Market Report 2024, The neoantigen targeted therapies market size has grown exponentially in recent years. It will grow from .43 billion in 2023 to .39 billion in 2024 at a compound annual growth rate (CAGR) of 39.3%.  The  growth in the historic period can be attributed to advancements in genomic sequencing, immunotherapy evolution, understanding tumor immunology, clinical success of checkpoint inhibitors, molecular profiling advancements.

The neoantigen targeted therapies market size is expected to see exponential growth in the next few years. It will grow to .69 billion in 2028 at a compound annual growth rate (CAGR) of 36.3%.  The growth in the forecast period can be attributed to advancements in bioinformatics, precision medicine expansion, neoantigen vaccine development, therapeutic combination strategies, biomarker validation. Major trends in the forecast period include neoantigen resistance management, neoantigen-primed adoptive cell therapies, neoantigen-based combinatorial therapies, integration of real-world data, enhanced predictive models.

The increasing incidence of cancer cases is expected to propel the growth of the neoantigen targeted therapies market going forward. The incidence of cancer refers to the number of new cases of cancer in a specific population for a given period. Neoantigen targeted therapies are often used in combination to treat different types of cancer. For instance, the American Cancer Society (ACS), a US-based voluntary health organization, in 2022, the United States had 1.9 million new cancer cases, representing a significant increase compared to previous years. Furthermore, in 2022, in the US, approximately 609,360 deaths were attributed to cancer, emphasizing the profound severity and impact of this disease on individuals and their families. Therefore, the increasing incidence of cancer cases is driving the growth of the neoantigen targeted therapies market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=11944&type=smp

The neoantigen targeted therapies market covered in this report is segmented –

1) By Type: Monotherapy, Combination Therapy

2) By Immunotherapy Type: DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies

3) By Target Disease Indication: Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer

4) By Route of Administration: Intradermal, Intravenous, Subcutaneous

5) By Application: Medical Research Institution, Hospital, and Clinic, Other Applications

Product innovation has emerged as a key trend gaining popularity in the neoantigen targeted therapies market. Major players are focusing on creating innovative products to lead the market. For instance, in October 2021, BioNTech, a Germany-based biotechnology company, expanded its clinical oncology portfolio with the initiation of a Phase 2 clinical trial for ‘BNT122’, a mRNA-based individualized immunotherapy. This trial specifically focuses on colorectal cancer patients. The trial marks an important milestone, as the first patient has been dosed with BNT122. It is designed to harness the power of the immune system by stimulating a targeted T-cell response against neoantigens found in each patient's tumor. The ongoing clinical trial represents an important step forward in BioNTech's mission to develop cutting-edge immunotherapies and expand the treatment options available to cancer patients.

The neoantigen targeted therapies market report table of contents includes:

1. Executive Summary

2. Neoantigen Targeted Therapies Market Characteristics

3. Neoantigen Targeted Therapies Market Trends And Strategies

4. Neoantigen Targeted Therapies Market - Macro Economic Scenario

5. Global Neoantigen Targeted Therapies Market Size and Growth

.................

32. Global Neoantigen Targeted Therapies Market Competitive Benchmarking

33. Global Neoantigen Targeted Therapies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neoantigen Targeted Therapies Market

35. Neoantigen Targeted Therapies Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info